SEMA6A
Gene Information
- Official Symbol: SEMA6A
- Official Name: semaphorin 6A
- Aliases and Previous Symbols: N/A
- Entrez ID: 57556
- UniProt: Q9H2E6
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: N/A
- UniProt Summary: Cell surface receptor for PLXNA2 that plays an important role in cell-cell signaling. Required for normal granule cell migration in the developing cerebellum. Promotes reorganization of the actin cytoskeleton and plays an important role in axon guidance in the developing central nervous system. Can act as repulsive axon guidance cue. Has repulsive action towards migrating granular neurons. May play a role in channeling sympathetic axons into the sympathetic chains and controlling the temporal sequence of sympathetic target innervation (By similarity). {ECO:0000250}.
Pfam Domains GO Terms
Pfam Domains
| Sema |
| PSI |
GO Terms
| negative regulation of cell adhesion involved in sprouting angiogenesis |
| regulation of cell adhesion involved in sprouting angiogenesis |
| negative regulation of vascular endothelial growth factor signaling pathway |
| negative regulation of cellular response to vascular endothelial growth factor stimulus |
| positive regulation of neuron migration |
| regulation of vascular endothelial growth factor signaling pathway |
| regulation of cellular response to vascular endothelial growth factor stimulus |
| semaphorin receptor binding |
| negative regulation of sprouting angiogenesis |
| negative regulation of axon extension involved in axon guidance |
| chemorepellent activity |
| negative regulation of axon guidance |
| regulation of axon extension involved in axon guidance |
| semaphorin-plexin signaling pathway |
| cellular response to vascular endothelial growth factor stimulus |
| regulation of neuron migration |
| negative regulation of axon extension |
| regulation of axon guidance |
| negative chemotaxis |
| neural crest cell migration |
| negative regulation of chemotaxis |
| negative regulation of ERK1 and ERK2 cascade |
| regulation of sprouting angiogenesis |
| negative regulation of axonogenesis |
| neural crest cell development |
| stem cell development |
| mesenchymal cell development |
| neural crest cell differentiation |
| regulation of axon extension |
| negative regulation of cell morphogenesis involved in differentiation |
| negative regulation of angiogenesis |
| negative regulation of developmental growth |
| negative regulation of blood vessel morphogenesis |
| regulation of extent of cell growth |
| negative regulation of vasculature development |
| negative regulation of cellular response to growth factor stimulus |
| negative regulation of neuron projection development |
| mesenchymal cell differentiation |
| stem cell differentiation |
| negative regulation of MAPK cascade |
| ameboidal-type cell migration |
| regulation of cell size |
| negative regulation of cell projection organization |
| negative regulation of cell growth |
| regulation of axonogenesis |
| regulation of chemotaxis |
| mesenchyme development |
| negative regulation of neuron differentiation |
| negative regulation of growth |
| axon guidance |
| neuron projection guidance |
| regulation of cellular response to growth factor stimulus |
| negative regulation of cell adhesion |
| regulation of angiogenesis |
| negative regulation of neurogenesis |
| regulation of ERK1 and ERK2 cascade |
| axon |
| regulation of cell morphogenesis involved in differentiation |
| negative regulation of cellular component movement |
| negative regulation of nervous system development |
| regulation of vasculature development |
| negative regulation of locomotion |
| regulation of developmental growth |
| negative regulation of cell development |
| negative regulation of response to external stimulus |
| axonogenesis |
| regulation of cellular component size |
| negative regulation of protein phosphorylation |
| axon development |
| regulation of cell growth |
| cell morphogenesis involved in neuron differentiation |
| negative regulation of phosphorylation |
| positive regulation of neurogenesis |
| neuron projection morphogenesis |
| plasma membrane bounded cell projection morphogenesis |
| cell projection morphogenesis |
| regulation of cell morphogenesis |
| regulation of neuron projection development |
| cellular response to growth factor stimulus |
| positive regulation of cell migration |
| negative regulation of intracellular signal transduction |
| regulation of anatomical structure size |
| cell part morphogenesis |
| positive regulation of cell motility |
| response to growth factor |
| positive regulation of nervous system development |
| positive regulation of cellular component movement |
| positive regulation of cell development |
| chemotaxis |
| taxis |
| positive regulation of locomotion |
| cell morphogenesis involved in differentiation |
| negative regulation of phosphate metabolic process |
| negative regulation of phosphorus metabolic process |
| negative regulation of protein modification process |
| regulation of neuron differentiation |
| neuron projection development |
| regulation of growth |
| regulation of cell adhesion |
| regulation of plasma membrane bounded cell projection organization |
| negative regulation of cellular component organization |
| regulation of cell projection organization |
| negative regulation of cell differentiation |
| cell morphogenesis |
| regulation of MAPK cascade |
| neuron development |
| regulation of neurogenesis |
| cellular component morphogenesis |
| regulation of cell migration |
| regulation of cell motility |
| apoptotic process |
| regulation of nervous system development |
| regulation of cell development |
| negative regulation of developmental process |
| animal organ morphogenesis |
| cell migration |
| positive regulation of cell differentiation |
| regulation of locomotion |
| regulation of cellular component movement |
| neuron differentiation |
| negative regulation of cellular protein metabolic process |
| programmed cell death |
| regulation of anatomical structure morphogenesis |
| localization of cell |
| cell motility |
| cell death |
| regulation of response to external stimulus |
| negative regulation of protein metabolic process |
| cytoskeleton organization |
| plasma membrane bounded cell projection organization |
| cell projection organization |
| negative regulation of multicellular organismal process |
| negative regulation of signal transduction |
| locomotion |
| negative regulation of cell communication |
| negative regulation of signaling |
| positive regulation of developmental process |
| integral component of plasma membrane |
| regulation of protein phosphorylation |
| generation of neurons |
| movement of cell or subcellular component |
| regulation of phosphorylation |
| extracellular space |
| negative regulation of response to stimulus |
| neurogenesis |
| cell development |
| positive regulation of multicellular organismal process |
| tissue development |
| regulation of phosphate metabolic process |
| regulation of phosphorus metabolic process |
| regulation of cell differentiation |
| regulation of intracellular signal transduction |
| regulation of protein modification process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
| Screen | Score |
|---|---|
| AICAR 240μM R03 exp116 | 1.7 |
| TRAIL 5ng/ml R00 exp35 | 1.85 |
Most Correlated Genes in Chemogenomics
No correlation found to any other genes in chemogenomics.
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 0/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 8647
- Expression level (log2 read counts): 2.59
Expression Distribution
SEMA6A Expression in NALM6 Cells: 2.59
